Beam Therapeutics Inc. (BEAM) vs Celldex Therapeutics, Inc. (CLDX)
Beam Therapeutics Inc. and Celldex Therapeutics, Inc. are both Biotechnology companies. Beam Therapeutics Inc. and Celldex Therapeutics, Inc. are of similar size ($2.6B and $2.5B). Beam Therapeutics Inc. grew revenue faster over the last twelve months: 158.9% against −88.3%. Beam Therapeutics Inc. has the higher net margin (−55.5% vs −33,883.8%) and the lower return on invested capital (−1,599.3% vs 0.00%). Across the 17 metrics below, Beam Therapeutics Inc. leads on 13 and Celldex Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | BEAM | CLDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (242.27%) | (36,733.82%) | 0.00% |
| Net margin | (55.45%) | (33,883.77%) | 0.00% |
| Free cash flow margin | (238.90%) | (27,294.81%) | 0.00% |
| Return on equity | (8.18%) | (43.88%) | (57.72%) |
| Return on assets | (6.23%) | (40.76%) | (49.22%) |
| Return on invested capital | (1,599.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack